Skip to main content

AMERISAFE, Inc. (AMSF) Stock Forecast

Data as of May 8, 2026

Financial Services · Current price $30.23 (-0.25%)

Consensus Target
$57.50
Upside
+46.5%
Analysts
4
Rating
Buy(2.50)

Price Target Range

Low $55.00Consensus $57.50High $60.00
▲ Current $30.23

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Buy
Strong Buy0
Buy1
Hold2
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

AMSF vs Sector & Market

MetricAMSFFinancial Services AvgLarge Cap Avg
Analyst Rating2.502.512.41
Analyst Count4818
Target Upside+46.5%+64.8%+14.9%
P/E Ratio12.46-4.7627.95

Revenue Estimates

PeriodLowAvgHigh#
2026-06-30$86M$86M$86M1
2026-09-30$86M$86M$86M1
2026-12-31$75M$75M$75M1
2027-03-31$96M$96M$96M1
2027-06-30$92M$92M$92M1
2027-09-30$92M$92M$92M1
2027-12-31$80M$80M$80M1

EPS Estimates

PeriodLowAvgHigh#
2026-06-30$0.52$0.52$0.521
2026-09-30$0.54$0.54$0.541
2026-12-31$0.54$0.54$0.541
2027-03-31$0.52$0.52$0.521
2027-06-30$0.53$0.53$0.531
2027-09-30$0.51$0.51$0.511
2027-12-31$0.50$0.50$0.501

Frequently Asked Questions

What is the analyst consensus for AMSF?

The consensus among 4 analysts covering AMERISAFE, Inc. (AMSF) is Buy with an average price target of $57.50.

What is the highest price target for AMSF?

The highest analyst price target for AMSF is $60.00.

What is the lowest price target for AMSF?

The lowest analyst price target for AMSF is $55.00.

How many analysts cover AMSF?

4 analysts have issued ratings for AMERISAFE, Inc. in the past 12 months.

Is AMSF a buy or sell right now?

Based on 4 analyst ratings, AMSF has a consensus rating of Buy (2.50/5) with a +46.5% upside to the consensus target of $57.50.

What are the earnings estimates for AMSF?

Analysts estimate AMSF will report EPS of $0.52 for the period ending 2026-06-30, with revenue estimated at $86M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.